These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 13043030)

  • 21. Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man.
    Levy G; Procknal JA
    J Pharm Sci; 1968 Aug; 57(8):1330-5. PubMed ID: 5677334
    [No Abstract]   [Full Text] [Related]  

  • 22. [Salicylamide].
    REIPERT R
    Dtsch Med Wochenschr; 1951 Oct; 76(42):1312. PubMed ID: 14896774
    [No Abstract]   [Full Text] [Related]  

  • 23. [Salicylamide in chemistry and pharmacology].
    REICHERT B
    Arzneimittelforschung; 1953 May; 3(5):255-6. PubMed ID: 13081471
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of intramuscular administration of salicylamide].
    HILLER E
    Arzneimittelforschung; 1953 May; 3(5):256-8. PubMed ID: 13081472
    [No Abstract]   [Full Text] [Related]  

  • 25. The analgesic and antipyretic properties of some derivatives of salicylamide.
    BAVIN EM; MACRAE FJ; SEYMOUR DE; WATERHOUSE PD
    J Pharm Pharmacol; 1952 Nov; 4(11):872-8. PubMed ID: 13000663
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of topically applied salicylic compounds on serotonin-induced scratching behaviour in hairless rats.
    Thomsen JS; Simonsen L; Benfeldt E; Jensen SB; Serup J
    Exp Dermatol; 2002 Aug; 11(4):370-5. PubMed ID: 12190947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Salicylamide excretion by the human organism].
    HOFFMANN W
    Arzneimittelforschung; 1955 Dec; 5(12):723-6. PubMed ID: 13293082
    [No Abstract]   [Full Text] [Related]  

  • 28. A study of the metabolism of C14 salicylamide in the human.
    MANDEL HG; RODWELL VW; SMITH PK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):433-9. PubMed ID: 13023553
    [No Abstract]   [Full Text] [Related]  

  • 29. [Salicylamide and salicylic acid poisoning in the cat in comparison with other animals. 3].
    BEKEMEIER H; HASCHEN RJ; SEIPELT H
    Arzneimittelforschung; 1962 Jul; 12():707-9. PubMed ID: 13866648
    [No Abstract]   [Full Text] [Related]  

  • 30. Antipyretic properties of some metabolic and structural analogues of sodium salicylate.
    Cranston WI; Luff RH; Rawlins MD
    J Physiol; 1971 Jul; 216(2):81P-82P. PubMed ID: 5559647
    [No Abstract]   [Full Text] [Related]  

  • 31. [The analgesic potency of acetylsalicylic acid and salicylamide; algesiametric measurements and their results in practice].
    HOFFMANN F
    Arztl Wochensch; 1953 Jul; 8(29):698-701. PubMed ID: 13080058
    [No Abstract]   [Full Text] [Related]  

  • 32. [Salicylamide as an analgesic and antirheumatic; results of a two year test].
    KERSCHENSTEINER A; KUSCHE E
    Med Monatsschr; 1953 Mar; 7(3):181-3. PubMed ID: 13071597
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of the sodium salts of benzoic and salicylic acids, of their para-amino compounds, and of salicylamide on oxygen consumption and body temperature of the rat].
    BALOGH L; DONHOFFER S; MESTYAN G; PAP T; TOTH I
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1952; 214(3):299-307. PubMed ID: 14934168
    [No Abstract]   [Full Text] [Related]  

  • 34. [Two cases of salicylamide allergy].
    HAMRIN B; NORDSTROM S
    Sven Lakartidn; 1952 Jul; 49(29):1865-71. PubMed ID: 13015429
    [No Abstract]   [Full Text] [Related]  

  • 35. Salicylamide I. Absorption, excretion, and blood levels.
    CRAMPTON JM; VOSS E
    J Am Pharm Assoc Am Pharm Assoc; 1954 Aug; 43(8):470-3. PubMed ID: 13191992
    [No Abstract]   [Full Text] [Related]  

  • 36. [Protective effect of some salicylic derivatives on experimental acute pulmonary edema. II. Effect of sodium salicylate].
    TESTONI F; LOMEO G; TOMMASELLI A
    Boll Soc Ital Biol Sper; 1955; 31(7-8):1044-6. PubMed ID: 13315787
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contribution on an aminophenazone-salicylamide combined preparation in therapy of rheumatic conditions].
    WEISS W
    Med Klin; 1956 Feb; 51(5):181-2. PubMed ID: 13308708
    [No Abstract]   [Full Text] [Related]  

  • 38. [Proposals for the DAB 7. 6. Acetanilid, acetylsalicylic acid, salicylic acid, sodium salicylate].
    BORNKESSEL S; RICHTER J
    Pharm Zentralhalle Dtschl; 1959 May; 98():246-51. PubMed ID: 13802893
    [No Abstract]   [Full Text] [Related]  

  • 39. Dissolution kinetics of a three-component solid II: benzoic acid, salicylic acid, and salicylamide.
    Parrott EL; Simpson M; Flanagan DR
    J Pharm Sci; 1983 Jul; 72(7):765-8. PubMed ID: 6886982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A note on serum levels and excretion of salicylamide in man.
    HIDALGO J; SEEBERG VP
    J Am Pharm Assoc Am Pharm Assoc; 1955 Jun; 44(6):384. PubMed ID: 14381318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.